AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine ...

Surufatinib, an oral angioimmuno kinase inhibitor, is approved for treating inoperable or late-stage, low-grade (G1 and G2), well-differentiated pNETs and extrapancreatic neuroendocrine tumors. This ...

BACKGROUND: Pancreatic neuroendocrine tumors (PNETs) are uncommon and heterogeneous neoplasms, often exhibiting indolent biological behavior. Their incidence is rising, largely due to the widespread ...

While broken heart syndrome is still somewhat of a medical mystery, its seriousness is increasingly clear, especially for men. As research evolves, the hope is to identify more precise treatments ...

Men are over twice as likely to die from takotsubo cardiomyopathy. The mortality rate for men was 11.2%, compared to 5.5% for women. Takotsubo cardiomyopathy can mimic heart attack symptoms and is ...

A recent study reveals a concerning trend: men are twice as likely to die from stress-induced heart failure, or broken heart syndrome, compared to women, despite women comprising most cases.

A new study from the Journal of the American Heart Association (JAHA) found that men die from a condition known as “broken heart syndrome” at more than twice the rate that women do.